Article
The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
American journal of clinical pathology - 1 Jan 2003
Ross Jeffrey S, Ginsburg Geoffrey S
Abstract excerpt
It is widely anticipated that during the next 5 years the molecular diagnostic industry will continue to grow at double-digit pace to meet increasing demand for personalized medicine. A wide variety of drugs in late preclinical and early clinical development are being targeted to disease-specific gene and protein defects that will require coapproval of diagnostic and therapeutic products by regulatory agencies....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.